688739.SS
688739.SS
CNE100004ZP2
LIAONING CHENGDA BIOTECHNOLOGY
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.390.287.449 1.676.241.144
17.1%
Cost of Revenue 286.816.834 286.002.805
0.3%
Gross Profit 1.103.470.615 1.390.238.338
20.6%
906.490.786 936.682.137
3.2%
Operating Income 196.979.829 453.556.201
56.6%
Pretax Income 169.604.544 403.024.938
57.9%
Net Income Common Stockholders 131.790.329 342.821.554
61.6%
-- --
--
-- --
--
ende